Anabolic Therapy in Postmenopausal Osteoporosis

NCT05010590 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Romosozumab
DRUG: Denosumab

Sponsor

Massachusetts General Hospital